Home » Pfizer’s Embeda Shows Positive Late Study Results
Pfizer’s Embeda Shows Positive Late Study Results
Pfizer said that its extended-release Embeda capsules performed better than another painkiller and a placebo in two late-stage studies on the potential for abuse.
MarketWatch
MarketWatch
Upcoming Events
-
07May
-
14May
-
30May